12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Company News  |  Other News

Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck, Sanofi, Bill & Melinda Gates Foundation, Infectious Disease Research Institute (IDRI), National I

The seven pharmaceutical companies have opened up sections of their compound libraries and agreed to share data with each other and the research institutions under the Gates Foundation's TB Drug Accelerator (TBDA) program to discover treatments for tuberculosis (TB). The program shifted last year to implementing assays and tools into a drug discovery effort from building the assays...

Read the full 270 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >